[contentcards url=”https://childrenshealthdefense.org/defender/rsv-monoclonal-antibody-shot-linked-drug-resistant-rsv-strains-infants/” target=”_blank”] by Brenda Baletti, Ph.D. A “substantial proportion” of infants immunized against the RSV virus with the monoclonal antibody shot nirsevimab — marketed by Sanofi and…
Posts tagged as “nirsevimab”
[contentcards url=”https://childrenshealthdefense.org/defender/rsv-monoclonal-antibody-shot-infants/” target=”_blank”] Advisors to the U.S. Food and Drug Administration on Thursday recommended approval of AstraZeneca’s new monoclonal antibody, which the drugmaker said is…